Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.

Abstract

There has been substantial progress in preventing and treating CMV infection. Prophylaxis with CMV screened blood products, IVIG and antiviral drugs (high dose acyclovir and/or Ganciclovir) considerably reduce the incidence of CMV disease and nearly eliminate CMV pneumonia after allogeneic BMT.

Cite this paper

@article{Devergie1994ProgressIT, title={Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.}, author={Agn{\'e}s Devergie and Richard Traineau and H. Esperou-Bourdeau and Patricia Ribaud and G{\'e}rard Soci{\'e} and Patrice Richard and Fekrije Selimi and Ika Hirsch and Eliane Gluckman}, journal={Nouvelle revue française d'hématologie}, year={1994}, volume={36 Suppl 1}, pages={S89-90} }